While 2025's IPO boom is likely being enjoyed by Wall Street’s investment bankers, it may be even better news for private ...

Medical supply giant Medline's shares rose 41% above their offer price in their hotly anticipated New York debut on Wednesday, rounding out a strong year for U.S. IPOs with volumes hitting their ...

First-time share sales in the U.S. this year have raised a combined $46.15 billion — excluding blank-check firms — the ...

Jim Boyle, Medline CEO, celebrates with others as medical supplies giant Medline (MDLN) holds it's IPO at Nasdaq stock market ...

It priced the offering at $29 a share. In its prospectus, the company said it has experienced more than 50 years of ...

Medline shares rose 20.7% in their hotly anticipated New York debut today, valuing the medical supply giant at $46 billion in the largest U.S. initial public offering since Rivian’s 2021 listing, ...

At $6.26 billion, Medline is just the fifth US-listed firm to raise more than $5 billion in an IPO over the past decade, data ...

Wall Street is getting a glimpse of what could be the biggest year ever for IPOs in the U.S. After four years of choppiness ...

Medline will debut on the Nasdaq later on Wednesday after the U.S. medical supply giant raised $6.26 billion in the biggest ...

Hashkey Holdings shares slid 3% on debut after raising $206 million via an Initial public offering in Hong Kong.

Despite a U.S. government shutdown that hit the "pause" button on new initial public offerings, the IPO market is expected to finish 2025 as it started, with a flurry of newly minted publicly ...